HIV-mediated expression of Btk in hematopoietic stem cells is not sufficient to restore B cell function in X-linked immunodeficient mice

Journal of Nippon Medical School

Volumn 72, Issue 4, 2005, Pages 203-212

  Tanabe, Hiroko ^a   Miyake, Koichi ^a   Shimada, Takashi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Btk; Gene therapy; HIV vector; XLA

Indexed keywords

BRUTON TYROSINE KINASE; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; NITROPHENOL; VIRUS VECTOR;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; BONE MARROW; CELL COUNT; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE SEVERITY; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; HEMATOPOIETIC STEM CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL ASSESSMENT; MOUSE; NONHUMAN; PROMOTER REGION; SIGNAL TRANSDUCTION; STEM CELL; X LINKED AGAMMAGLOBULINEMIA;

ANIMALS; B-LYMPHOCYTES; HEMATOPOIETIC STEM CELLS; MICE; MICE, SCID; PROTEIN-TYROSINE KINASES; SEVERE COMBINED IMMUNODEFICIENCY;

EID: 25144488563     PISSN: 13454676     EISSN: 13473409     Source Type: Journal    
DOI: 10.1272/jnms.72.203     Document Type: Article

References (35)

1. Tsukada S, Saffran DC, Rawlings DJ, Parolini O, Allen RC, Klisak I, Sparkes RS, Kubagawa H, Mohandas T, Quan S, Belmont JW, Cooper MD, Conley ME, Witte ON: Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 1993; 72: 279-290.
2. Campana D, Farrant J, Inamdar N, Webster AD, Janossy G: Phenotypic features and proliferative activity of B cell progenitors in X-linked agammaglobulinemia. J Immunol 1990; 145: 1675-1680.
3. Rosen FS, Cooper MD, Wedgwood RJ: The primary immunodeficiencies. N Engl J Med 1995; 333: 431-440.
4. Rawlings DJ, Saffran DC, Tsukada S, Largaespada DA, Grimaldi JC, Cohen L, Mohr RN, Bazan JF, Howard M, Copeland NG, Jenkins NA, Witte ON: Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 1993; 261: 358-361.
5. Thomas JD, Sideras P, Smith CI, Vorechovsky I, Chapman V, Paul WE: Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science 1993; 261: 355-358.
6. Hardy RR, Hayakawa K, Parks DR, Herzenberg LA: Demonstration of B-cell maturation in X-linked immunodeficient mice by simultaneous three-colour immunofluorescence. Nature 1983; 306: 270-272.
7. Perlmutter RM, Nahm M, Stein KE, Slack J, Zitron I, Paul WE, Davie JM: Immunoglobulin subclass-specific immunodeficiency in mice with an X-linked B-lymphocyte defect. J Exp Med 1979; 149: 993-998.
8. Wicker LS, Scher I: X-linked immune deficiency (xid) of CBA/N mice. Curr Top Microbiol Immunol 1986; 124: 87-101.
9. Quartier P, Debre M, De Blic J, de Sauverzac R, Sayegh N, Jabado N, Haddad E, Blanche S, Casanova JL, Smith CI, Le Deist F, de Saint BG, Fischer A: Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients. J Pediatr 1999; 134: 589-596.
10. Rohrer J, Conley ME: Correction of X-linked immunodeficient mice by competitive reconstitution with limiting numbers of normal bone marrow cells. Blood 1999; 94: 3358-3365.
11. Drabek D, Raguz S, De Wit TP, Dingjan GM, Savelkoul HF, Grosveld F, Hendriks RW: Correction of the X-linked immunodeficiency phenotype by transgenic expression of human Bruton tyrosine kinase under the control of the class II major histocompatibility complex Ea locus control region. Proc Natl Acad Sci USA 1997; 94: 610-615.
12. Conley ME, Rohrer J, Rapalus L, Boylin EC, Minegishi Y: Defects in early B-cell development: comparing the consequences of abnormalities in pre-BCR signaling in the human and the mouse. Immunol Rev 2000; 178: 75-90.
13. Miyoshi H, Blomer U, Takahashi M, Gage FH, Verma IM: Development of a self-inactivating lentivirus vector. J Virol 1998; 72: 8150-8157.
14. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM: In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272: 263-267.
15. Igarashi T, Miyake K, Kato K, Watanabe A, Ishizaki M, Ohara K, Shimada T: Lentivirus-mediated expression of angiostatin efficiency inhibits neovascularization in a murine proliferative retinopathy model. Gene Ther 2003; 10: 219-226.
16. Tahara-Hanaoka S, Sudo K, Ema H, Miyoshi H, Nakauchi H: Lentiviral vector-mediated transduction of murine CD34 (-) hematopoietic stem cells. Exp Hematol 2002; 30: 11-17.
17. Oka Y, Rolink AG, Andersson J, Kamanaka M, Uchida J, Yasui T, Kishimoto T, Kikutani H, Melchers F: Profound reduction of mature B cell numbers, reactivities and serum Ig levels in mice which simultaneously carry the XID and CD40 deficiency genes. Int Immunol 1996; 8: 1675-1685.
18. Hayakawa K, Hardy RR, Stall AM, Herzenberg LA, Herzenberg LA: Immunoglobulin-bearing B cells reconstitute and maintain the murine Ly-1 B cell lineage. Eur J Immunol 1986; 16: 1313-1316.
19. Scherr M, Eder M: Gene transfer into hematopoietic stem cells using lentiviral vectors. Curr Gene Ther 2002; 2: 45-55.
20. Hoeben RC, Migchielsen AA, van der Jagt RC, van Ormondt H, van der Eb AJ: Inactivation of the Moloney murine leukemia virus long terminal repeat in murine fibroblast cell lines is associated with methylation and dependent on its chromosomal position. J Virol 1991; 65: 904-912.
21. Palmer TD, Rosman GJ, Osborne WR, Miller AD: Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc Natl Acad Sci USA 1991; 88: 1330-1334.
22. Challita PM, Kohn DB: Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc Natl Acad Sci USA 1994; 91: 2567-2571.
23. Klug CA, Cheshier S, Weissman IL: Inactivation of a GFP retrovirus occurs at multiple levels in long-term repopulating stem cells and their differentiated progeny. Blood 2000; 96: 894-901.
24. Miyoshi H, Smith KA, Mosier DE, Verma IM, Torbett BE: Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 1999; 283: 682-686.
25. Satterthwaite AB, Cheroutre H, Khan WN, Sideras P, Witte ON: Btk dosage determines sensitivity to B cell antigen receptor cross-linking. Proc Natl Acad Sci USA 1997; 94: 13152-13157.
26. Yu PW, Tabuchi RS, Kato RM, Astrakhan A, Humblet-Baron S, Kipp K, Chae K, Ellmeier W, Witte ON, Rawlings DJ: Sustained correction of B-cell development and function in a murine model of X-linked agammaglobulinemia (XLA) using retroviral-mediated gene transfer. Blood 2004; 104: 1281-1290.
27. Ellmeier W, Jung S, Sunshine MJ, Hatam F, Xu Y, Baltimore D, Mano H, Littman DR: Severe B cell deficiency in mice lacking the tec kinase family members Tec and Btk. J Exp Med 2000; 192: 1611-1624.
28. De Weers M, Dingjan GM, Brouns GS, Kraakman ME, Mensink RG, Lovering RC, Schuurman RK, Borst J, Hendriks RW: Expression of Bruton's tyrosine kinase in B lymphoblastoid cell lines from X-linked agammaglobulinaemia patients. Clin Exp Immunol 1997; 107: 235-240.
29. Hashimoto S, Tsukada S, Matsushita M, Miyawaki T, Niida Y, Yachie A, Kobayashi S, Iwata T, Hayakawa H, Matsuoka H, Tsuge I, Yamadori T, Kunitaka T, Arai S, Yoshizaki K, Taniguchi N, Kishimoto T: Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan. Blood 1996; 88: 561-573.
30. Maas A, Hendriks RW: Role of Bruton's tyrosine kinase in B cell development. Dev Immunol 2001; 8: 171-181.
31. Uckun FM, Waddick KG, Mahajan S, Jun X, Takata M, Bolen J, Kurosaki T: BTK as a mediator of radiation-induced apoptosis in DT-40 lymphoma B cells. Science 1996; 273: 1096-1100.
32. Islam TC, Branden LJ, Kohn DB, Islam KB, Smith CI: BTK mediated apoptosis, a possible mechanism for failure to generate high titer retroviral producer clones. J Gene Med 2000; 2: 204-209.
33. Nisitani S, Satterthwaite AB, Akashi K, Weissman IL, Witte ON, Wahl MI: Posttranscriptional regulation of Bruton's tyrosine kinase expression in antigen receptor-stimulated splenic B cells. Proc Natl Acad Sci USA 2000; 97: 2737-2742.
34. Maas A, Dingjan GM, Savelkoul HF, Kinnon C, Grosveld F, Hendriks RW: The X-linked immunodeficiency defect in the mouse is corrected by expression of human Bruton's tyrosine kinase from a yeast artificial chromosome transgene. Eur J Immunol 1997; 27: 2180-2187.
35. Pinschewer DD, Ochsenbein AF, Satterthwaite AB, Witte ON, Hengartner H, Zinkernagel RM: A Btk transgene restores the antiviral TI-2 antibody responses of xid mice in a dose-dependent fashion. Eur J Immunol 1999; 29: 2981-2987.